Form 8-K - Current report:
SEC Accession No. 0001021408-02-011997
Filing Date
2002-09-25
Accepted
2002-09-25 13:43:54
Documents
2
Period of Report
2002-09-24
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.txt 8-K 2927
3 PRESS RELEASE DATED SEP. 25, 2002 dex991.txt EX-99.1 2814
  Complete submission text file 0001021408-02-011997.txt   7572
Mailing Address PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-27410 | Film No.: 02771900
SIC: 2834 Pharmaceutical Preparations